By Topic

Quantification of ultrasound contrast agent in an in vitro perfusion phantom

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

6 Author(s)
Bridal, S.L. ; Lab. d''Imagerie Parametrique, Paris VI Univ., France ; Lucidarme, O. ; Correas, J.-M. ; Burns, P.N.
more authors

Contrast agents improve the diagnostic capability of ultrasonic imaging. Optimized methods for agent administration and quantification of signal enhancement, however, remain under development. The authors' purpose was to develop an in vitro perfusion phantom in order to compare quantification methods. The acoustic response of contrast agent was measured simultaneously with a reference method (radio frequency RF signal analysis) and techniques more readily available in the clinic (continuous wave CW Doppler, B-mode and power Doppler cineloops). Quantitative parameters (RF integrated backscatter and attenuation; CW Doppler, B-mode and power Doppler intensity) were compared as a function of time after injection of EchoGen(R) or SonoVueTM. A good correlation was found between integrated backscatter, CW Doppler and power Doppler intensities. Shadowing in B-mode images of the phantom were found to be correlated with measured attenuation. The relationships established provide a first step toward more quantitative clinical assessment of contrast enhancement

Published in:

Ultrasonics Symposium, 1999. Proceedings. 1999 IEEE  (Volume:2 )

Date of Conference:

1999